Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Cyclipostins and Cyclophostin analogs are multi-target inhibitors that impair growth of Mycobacterium abscessus.

Madani A, Ridenour JN, Martin BP, Paudel RR, Abdul Basir A, Le Moigne V, Herrmann JL, Audebert S, Camoin L, Kremer L, Spilling CD, Canaan S, Cavalier JF.

ACS Infect Dis. 2019 Jul 12. doi: 10.1021/acsinfecdis.9b00172. [Epub ahead of print]

PMID:
31299146
2.

Differential modification of the C. elegans proteome in response to acute and chronic gamma radiation: Link with reproduction decline.

Dubois C, Pophillat M, Audebert S, Fourquet P, Lecomte C, Dubourg N, Galas S, Camoin L, Frelon S.

Sci Total Environ. 2019 Aug 1;676:767-781. doi: 10.1016/j.scitotenv.2019.04.039. Epub 2019 Apr 23.

PMID:
31055208
3.

Identification of O-Glcnacylated Proteins in Trypanosoma cruzi.

Torres-Gutiérrez E, Pérez-Cervera Y, Camoin L, Zenteno E, Aquino-Gil MO, Lefebvre T, Cabrera-Bravo M, Reynoso-Ducoing O, Bucio-Torres MI, Salazar-Schettino PM.

Front Endocrinol (Lausanne). 2019 Mar 29;10:199. doi: 10.3389/fendo.2019.00199. eCollection 2019.

4.

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer.

Daulat AM, Finetti P, Revinski D, Silveira Wagner M, Camoin L, Audebert S, Birnbaum D, Kodjabachian L, Borg JP, Bertucci F.

Br J Cancer. 2019 Apr;120(9):931-940. doi: 10.1038/s41416-019-0448-z. Epub 2019 Apr 11.

5.

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.

Guerin M, Gonçalves A, Toiron Y, Baudelet E, Pophillat M, Granjeaud S, Fourquet P, Jacot W, Tarpin C, Sabatier R, Agavnian E, Finetti P, Adelaide J, Birnbaum D, Ginestier C, Charafe-Jauffret E, Viens P, Bertucci F, Borg JP, Camoin L.

Oncotarget. 2018 Sep 18;9(73):33762-33777. doi: 10.18632/oncotarget.26031. eCollection 2018 Sep 18.

6.

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial.

Lebellec L, Bertucci F, Tresch-Bruneel E, Ray-Coquard I, Le Cesne A, Bompas E, Blay JY, Italiano A, Mir O, Ryckewaert T, Toiron Y, Camoin L, Goncalves A, Penel N, Le Deley MC.

BMC Cancer. 2018 Oct 11;18(1):963. doi: 10.1186/s12885-018-4828-1.

7.

Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis.

Nguyen PC, Nguyen VS, Martin BP, Fourquet P, Camoin L, Spilling CD, Cavalier JF, Cambillau C, Canaan S.

J Mol Biol. 2018 Dec 7;430(24):5120-5136. doi: 10.1016/j.jmb.2018.09.017. Epub 2018 Oct 4.

PMID:
30292819
8.

Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.

Nguyen PC, Delorme V, Bénarouche A, Guy A, Landry V, Audebert S, Pophillat M, Camoin L, Crauste C, Galano JM, Durand T, Brodin P, Canaan S, Cavalier JF.

Bioorg Chem. 2018 Dec;81:414-424. doi: 10.1016/j.bioorg.2018.08.025. Epub 2018 Aug 29.

PMID:
30212765
9.

O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins.

Deracinois B, Camoin L, Lambert M, Boyer JB, Dupont E, Bastide B, Cieniewski-Bernard C.

J Proteomics. 2018 Aug 30;186:83-97. doi: 10.1016/j.jprot.2018.07.005. Epub 2018 Jul 26.

PMID:
30016717
10.

Mapping Cellular Polarity Networks Using Mass Spectrometry-based Strategies.

Daulat AM, Puvirajesinghe TM, Camoin L, Borg JP.

J Mol Biol. 2018 Sep 28;430(19):3545-3564. doi: 10.1016/j.jmb.2018.05.023. Epub 2018 May 18. Review.

11.

Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer.

Peltier J, Roperch JP, Audebert S, Borg JP, Camoin L.

Clin Proteomics. 2018 Apr 9;15:15. doi: 10.1186/s12014-018-9191-3. eCollection 2018.

12.

Reply: De-Escalation of the P2Y12 Inhibitor After Acute Coronary Syndromes According to On-Treatment Platelet Reactivity: A Promising Step of Enormous Magnitude That Should Be Explored.

Deharo P, Camoin L, Quilici J, Bonnet JL, Cuisset T.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):508-509. doi: 10.1016/j.jcin.2018.01.256. No abstract available.

13.

Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach.

Mokart D, Saillard C, Zemmour C, Bisbal M, Sannini A, Chow-Chine L, Brun JP, Faucher M, Boher JM, Toiron Y, Chabannon C, Borg JP, Gonçalves A, Camoin L.

Acta Anaesthesiol Scand. 2018 Apr;62(4):493-503. doi: 10.1111/aas.13060. Epub 2018 Jan 7.

PMID:
29315472
14.

Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo.

Viljoen A, Richard M, Nguyen PC, Fourquet P, Camoin L, Paudal RR, Gnawali GR, Spilling CD, Cavalier JF, Canaan S, Blaise M, Kremer L.

J Biol Chem. 2018 Feb 23;293(8):2755-2769. doi: 10.1074/jbc.RA117.000760. Epub 2018 Jan 4.

15.

EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.

Bouguenina H, Salaun D, Mangon A, Muller L, Baudelet E, Camoin L, Tachibana T, Cianférani S, Audebert S, Verdier-Pinard P, Badache A.

Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10687-E10696. doi: 10.1073/pnas.1705682114. Epub 2017 Nov 21.

16.

Diagnosis of Infective Endocarditis After TAVR: Value of a Multimodality Imaging Approach.

Salaun E, Sportouch L, Barral PA, Hubert S, Lavoute C, Casalta AC, Pradier J, Ouk D, Casalta JP, Lambert M, Gouriet F, Gaubert JY, Dehaene A, Jacquier A, Tessonnier L, Haentjens J, Theron A, Riberi A, Cammilleri S, Grisoli D, Jaussaud N, Collart F, Bonnet JL, Camoin L, Renard S, Cuisset T, Avierinos JF, Lepidi H, Mundler O, Raoult D, Habib G.

JACC Cardiovasc Imaging. 2018 Jan;11(1):143-146. doi: 10.1016/j.jcmg.2017.05.016. Epub 2017 Aug 16. No abstract available.

17.

Flow Cytometry Sorting to Separate Viable Giant Viruses from Amoeba Co-culture Supernatants.

Khalil JY, Langlois T, Andreani J, Sorraing JM, Raoult D, Camoin L, La Scola B.

Front Cell Infect Microbiol. 2017 Jan 6;6:202. doi: 10.3389/fcimb.2016.00202. eCollection 2016.

18.

Fibronectin-guided migration of carcinoma collectives.

Gopal S, Veracini L, Grall D, Butori C, Schaub S, Audebert S, Camoin L, Baudelet E, Radwanska A, Beghelli-de la Forest Divonne S, Violette SM, Weinreb PH, Rekima S, Ilie M, Sudaka A, Hofman P, Van Obberghen-Schilling E.

Nat Commun. 2017 Jan 19;8:14105. doi: 10.1038/ncomms14105.

19.

Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination.

Bonacci T, Audebert S, Camoin L, Baudelet E, Iovanna JL, Soubeyran P.

PLoS One. 2017 Jan 18;12(1):e0169988. doi: 10.1371/journal.pone.0169988. eCollection 2017.

20.

How may targeted proteomics complement genomic data in breast cancer?

Guerin M, Gonçalves A, Toiron Y, Baudelet E, Audebert S, Boyer JB, Borg JP, Camoin L.

Expert Rev Proteomics. 2017 Jan;14(1):43-54. doi: 10.1080/14789450.2017.1256776. Epub 2016 Nov 15. Review.

PMID:
27813428
21.

The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells.

Roncagalli R, Cucchetti M, Jarmuzynski N, Grégoire C, Bergot E, Audebert S, Baudelet E, Menoita MG, Joachim A, Durand S, Suchanek M, Fiore F, Zhang L, Liang Y, Camoin L, Malissen M, Malissen B.

J Exp Med. 2016 Oct 17;213(11):2437-2457. Epub 2016 Sep 19.

22.

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO).

Lebellec L, Bertucci F, Tresch-Bruneel E, Bompas E, Toiron Y, Camoin L, Mir O, Laurence V, Clisant S, Decoupigny E, Blay JY, Goncalves A, Penel N.

Oncotarget. 2016 Nov 8;7(45):73984-73994. doi: 10.18632/oncotarget.12172.

23.

Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.

Peltier J, Roperch JP, Audebert S, Borg JP, Camoin L.

J Proteomics. 2016 Oct 4;148:139-48. doi: 10.1016/j.jprot.2016.07.031. Epub 2016 Aug 2.

PMID:
27492143
24.

Src-family-tyrosine kinase Lyn is critical for TLR2-mediated NF-κB activation through the PI 3-kinase signaling pathway.

Toubiana J, Rossi AL, Belaidouni N, Grimaldi D, Pene F, Chafey P, Comba B, Camoin L, Bismuth G, Claessens YE, Mira JP, Chiche JD.

Innate Immun. 2015 Oct;21(7):685-97. doi: 10.1177/1753425915586075. Epub 2015 Jun 8.

PMID:
26055819
25.

Regulatory O-GlcNAcylation sites on FoxO1 are yet to be identified.

Fardini Y, Perez-Cervera Y, Camoin L, Pagesy P, Lefebvre T, Issad T.

Biochem Biophys Res Commun. 2015 Jun 26;462(2):151-8. doi: 10.1016/j.bbrc.2015.04.114. Epub 2015 May 2.

PMID:
25944660
26.

Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease.

Fraisier C, Papa A, Granjeaud S, Hintzen R, Martina B, Camoin L, Almeras L.

PLoS One. 2014 Apr 2;9(4):e93637. doi: 10.1371/journal.pone.0093637. eCollection 2014.

27.

Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins.

Bonacci T, Audebert S, Camoin L, Baudelet E, Bidaut G, Garcia M, Witzel II, Perkins ND, Borg JP, Iovanna JL, Soubeyran P.

J Proteome Res. 2014 May 2;13(5):2478-94. doi: 10.1021/pr401258d. Epub 2014 Apr 2.

PMID:
24654937
28.

Kinetic analysis of mouse brain proteome alterations following Chikungunya virus infection before and after appearance of clinical symptoms.

Fraisier C, Koraka P, Belghazi M, Bakli M, Granjeaud S, Pophillat M, Lim SM, Osterhaus A, Martina B, Camoin L, Almeras L.

PLoS One. 2014 Mar 11;9(3):e91397. doi: 10.1371/journal.pone.0091397. eCollection 2014.

29.

Essential and nonredundant roles for Diaphanous formins in cortical microtubule capture and directed cell migration.

Daou P, Hasan S, Breitsprecher D, Baudelet E, Camoin L, Audebert S, Goode BL, Badache A.

Mol Biol Cell. 2014 Mar;25(5):658-68. doi: 10.1091/mbc.E13-08-0482. Epub 2014 Jan 8. Erratum in: Mol Biol Cell. 2015 Jul 1;26(13):2573.

30.

Hepatocyte pathway alterations in response to in vitro Crimean Congo hemorrhagic fever virus infection.

Fraisier C, Rodrigues R, Vu Hai V, Belghazi M, Bourdon S, Paranhos-Baccala G, Camoin L, Almeras L, Peyrefitte CN.

Virus Res. 2014 Jan 22;179:187-203. doi: 10.1016/j.virusres.2013.10.013. Epub 2013 Oct 30.

PMID:
24184319
31.

Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).

Cuisset T, Grosdidier C, Loundou AD, Quilici J, Loosveld M, Camoin L, Pankert M, Beguin S, Lambert M, Morange PE, Bonnet JL, Alessi MC.

JACC Cardiovasc Interv. 2013 Aug;6(8):854-63. doi: 10.1016/j.jcin.2013.04.009.

32.

Altered protein networks and cellular pathways in severe west nile disease in mice.

Fraisier C, Camoin L, Lim SM, Bakli M, Belghazi M, Fourquet P, Granjeaud S, Osterhaus AD, Koraka P, Martina B, Almeras L.

PLoS One. 2013 Jul 10;8(7):e68318. doi: 10.1371/journal.pone.0068318. Print 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/a01d68f4-f23d-4c0a-a0f8-f32432b0efa7. Lim, Stéphanie [corrected to Lim, Stephanie M].

33.

Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis.

Million M, Walter G, Bardin N, Camoin L, Giorgi R, Bongrand P, Gouriet F, Casalta JP, Thuny F, Habib G, Raoult D.

Clin Infect Dis. 2013 Jul;57(1):57-64. doi: 10.1093/cid/cit191. Epub 2013 Mar 26.

PMID:
23532474
34.

Glial-cell-mediated re-induction of the blood-brain barrier phenotype in brain capillary endothelial cells: a differential gel electrophoresis study.

Deracinois B, Pottiez G, Chafey P, Teerlink T, Camoin L, Davids M, Broussard C, Couraud PO, Dehouck MP, Cecchelli R, Karamanos Y, Flahaut C.

Proteomics. 2013 Apr;13(7):1185-99. doi: 10.1002/pmic.201200166.

PMID:
23436736
35.

Effect of CYP2C19*2 and *17 genetic variants on platelet response to clopidogrel and prasugrel maintenance dose and relation to bleeding complications.

Grosdidier C, Quilici J, Loosveld M, Camoin L, Moro PJ, Saut N, Gaborit B, Pankert M, Cohen W, Lambert M, Beguin S, Morange PE, Bonnet JL, Alessi MC, Cuisset T.

Am J Cardiol. 2013 Apr 1;111(7):985-90. doi: 10.1016/j.amjcard.2012.12.013. Epub 2013 Jan 19.

PMID:
23340030
36.

Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Brégnard C, Zamborlini A, Leduc M, Chafey P, Camoin L, Saïb A, Benichou S, Danos O, Basmaciogullari S.

J Virol. 2013 Apr;87(7):3729-40. doi: 10.1128/JVI.02477-12. Epub 2013 Jan 16.

37.

Identification of proteins related to early changes observed in Human hepatocellular carcinoma cells after treatment with the mycotoxin Zearalenone.

Gazzah AC, Camoin L, Abid S, Bouaziz C, Ladjimi M, Bacha H.

Exp Toxicol Pathol. 2013 Sep;65(6):809-16. doi: 10.1016/j.etp.2012.11.007. Epub 2013 Jan 3.

PMID:
23290424
38.

Molecular characterisation of endogenous Vangl2/Vangl1 heteromeric protein complexes.

Belotti E, Puvirajesinghe TM, Audebert S, Baudelet E, Camoin L, Pierres M, Lasvaux L, Ferracci G, Montcouquiol M, Borg JP.

PLoS One. 2012;7(9):e46213. doi: 10.1371/journal.pone.0046213. Epub 2012 Sep 28.

39.

Proteomes of umbilical vein and microvascular endothelial cells reflect distinct biological properties and influence immune recognition.

Dib H, Chafey P, Clary G, Federici C, Le Gall M, Dwyer J, Gavard J, Tamas N, Bussone G, Broussard C, Camoin L, Witko-Sarsat V, Tamby MC, Mouthon L.

Proteomics. 2012 Aug;12(15-16):2547-55. doi: 10.1002/pmic.201200060.

PMID:
22903842
40.

iTRAQ: a method to elucidate cellular responses to mycotoxin zearalenone.

Gazzah AC, Camoin L, Abid S, Bacha H, Ladjimi M.

J Appl Toxicol. 2013 Jul;33(7):566-75. doi: 10.1002/jat.1766. Epub 2012 Jun 25.

PMID:
22729511
41.

Guanine nucleotide-binding protein Gαi2: a new partner of claudin-5 that regulates tight junction integrity in human brain endothelial cells.

Luissint AC, Federici C, Guillonneau F, Chrétien F, Camoin L, Glacial F, Ganeshamoorthy K, Couraud PO.

J Cereb Blood Flow Metab. 2012 May;32(5):860-73. doi: 10.1038/jcbfm.2011.202. Epub 2012 Feb 15.

42.

A differential proteomic approach identifies structural and functional components that contribute to the differentiation of brain capillary endothelial cells.

Pottiez G, Duban-Deweer S, Deracinois B, Gosselet F, Camoin L, Hachani J, Couraud PO, Cecchelli R, Dehouck MP, Fenart L, Karamanos Y, Flahaut C.

J Proteomics. 2011 Dec 21;75(2):628-41. doi: 10.1016/j.jprot.2011.09.002. Epub 2011 Sep 23.

PMID:
21982828
43.

Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1.

Thirant C, Varlet P, Lipecka J, Le Gall M, Broussard C, Chafey P, Studler JM, Lacombe J, Lions S, Guillaudeau A, Camoin L, Daumas-Duport C, Junier MP, Chneiweiss H.

Proteomics. 2011 Nov;11(21):4139-54. doi: 10.1002/pmic.201000646. Epub 2011 Sep 22.

PMID:
21898821
44.

Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.

Bussone G, Dib H, Tamby MC, Broussard C, Federici C, Woimant G, Camoin L, Guillevin L, Mouthon L.

Arthritis Res Ther. 2011 May 13;13(3):R74. doi: 10.1186/ar3336.

45.

Posttranslational modification of pili upon cell contact triggers N. meningitidis dissemination.

Chamot-Rooke J, Mikaty G, Malosse C, Soyer M, Dumont A, Gault J, Imhaus AF, Martin P, Trellet M, Clary G, Chafey P, Camoin L, Nilges M, Nassif X, Duménil G.

Science. 2011 Feb 11;331(6018):778-82. doi: 10.1126/science.1200729.

46.

Exploring the use of dimethylsulfate for in vivo proteome footprinting.

Moio P, Kulyyassov A, Vertut D, Camoin L, Ramankulov E, Lipinski M, Ogryzko V.

Proteomics. 2011 Jan;11(2):249-60. doi: 10.1002/pmic.200900832. Epub 2010 Dec 15.

PMID:
21204252
47.

Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after Acute Coronary Syndrome.

Cuisset T, Frere C, Moro PJ, Quilici J, Pons C, Gaborit B, Camoin L, Morange PE, Bonnet JL, Alessi MC.

Thromb Res. 2010 Nov;126(5):e400-2. doi: 10.1016/j.thromres.2010.08.009. Epub 2010 Sep 15. No abstract available.

PMID:
20828794
48.

Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation).

Poyet R, Cuisset T, Frere C, Quilici J, Gaborit B, Moro PJ, Camoin L, Morange PE, Bonnet JL, Alessi MC.

Thromb Res. 2010 Nov;126(5):e397-9. doi: 10.1016/j.thromres.2010.08.005. Epub 2010 Sep 9. No abstract available.

PMID:
20825983
49.

Modified expression of several sperm proteins after chronic exposure to the antiandrogenic compound vinclozolin.

Auger J, Eustache F, Maceiras P, Broussard C, Chafey P, Lesaffre C, Vaiman D, Camoin L, Auer J.

Toxicol Sci. 2010 Oct;117(2):475-84. doi: 10.1093/toxsci/kfq199. Epub 2010 Jul 8. Erratum in: Toxicol Sci. 2010 Dec;118(2):732.

PMID:
20616205
50.

Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology.

Auer J, Camoin L, Guillonneau F, Rigourd V, Chelbi ST, Leduc M, Laparre J, Mignot TM, Vaiman D.

J Proteomics. 2010 Mar 10;73(5):1004-17. doi: 10.1016/j.jprot.2009.12.014. Epub 2010 Jan 14.

PMID:
20079470

Supplemental Content

Loading ...
Support Center